Neurona Therapeutics
Clinical trials sponsored by Neurona Therapeutics, explained in plain language.
-
Brain cell injection could tame epilepsy seizures
Disease control Recruiting nowThis study tests a one-time injection of calming nerve cells (NRTX-1001) directly into the brain area causing seizures. It is for adults with drug-resistant mesial temporal lobe epilepsy who still have frequent seizures despite medication. The goal is to see if the treatment is s…
Phase: PHASE3 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:33 UTC
-
Brain cell transplant aims to quiet seizures in Drug-Resistant epilepsy
Disease control Recruiting nowThis early-stage trial tests a single injection of special nerve cells (NRTX-1001) into both sides of the brain for people with severe epilepsy that doesn't respond to medication. The goal is to see if it's safe and can reduce seizure frequency. Ten adults aged 18-75 with confirm…
Phase: PHASE1, PHASE2 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC